• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Adv Exp Med Biol . Pharmacophores of Influenza Virus PA Endonuclease Inhibitors

tetano

Editor, Senior Moderator
Adv Exp Med Biol


. 2026:1491:413-445.
doi: 10.1007/978-3-032-04153-1_25.
Pharmacophores of Influenza Virus PA Endonuclease Inhibitors

Dai Hatakeyama[SUP] 1 2 [/SUP], Masaki Shoji[SUP] 3 [/SUP], Takashi Kuzuhara[SUP] 4 [/SUP]


Affiliations
Abstract

With the emergence of the novel coronavirus in 2020, influenza viruses have remained out of the spotlight for some time. However, influenza viral infections have been reported in recent years, indicating that this pathogen remains a major threat. Therefore, in addition to elucidating the molecular mechanisms underlying viral proliferation, new drugs are being actively developed. One of the most effective targets for anti-influenza drugs is the endonuclease activity of the PA subunit, a component of the viral RNA-dependent polymerase, for which a wide variety of compounds have been reported to date. In this review, we introduce 100 compounds that inhibit the activity of this enzyme and the viral proliferation efficiency, showing their potential to be used as novel anti-influenza drugs.

Keywords: Divalent metal ion; Influenza virus; PA endonuclease.

 
Back
Top